Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by 1998novlon Jun 25, 2020 11:47am

142 Views

Post# 31190643

RE:RE:RE:The start of a better narrative

I think 80-85% of the 7Million shares traded were HFT (High Frequency traders) and went back and forth - so I don't see that as a headwind. But once we break out past $4.25 on a close then it should rip as the technicians will be buying back for no other reason than the charts. That should buy some time for some good fundamental news on HIV NASH etc

Bullboard Posts

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions